Evnin Luke (CIK 0001134657)

Latest company ownership

Shares held
4,381,062
Last filed at
Dec 12, 2024
Confidence Score
49.9
2025Q4
Confidence Score History
2021Q4 2025Q4
Shares held
3,196,463
Last filed at
Dec 4, 2025
Confidence Score
36.4
2026Q1
Confidence Score History
2021Q2 2026Q1
ALT - Altimmune, Inc.
Role: 10% Owner
Shares held
2,428,171
Last filed at
Nov 5, 2010
Confidence Score
50.0
2026Q1
Confidence Score History
2010Q4 2026Q1
Shares held
1,732,573
Last filed at
Oct 11, 2017
Confidence Score
50.0
2025Q4
Confidence Score History
2017Q4 2025Q4
Shares held
952,191
Last filed at
Jun 25, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q2 2025Q4
VSTM - Verastem, Inc.
Role: Other
Shares held
76,190
Last filed at
Feb 3, 2012
Confidence Score
50.0
2026Q1
Confidence Score History
2012Q1 2026Q1

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jan 5, 2026 Jan 7, 2026 Werewolf Therapeutics, Inc. Director Sell 44.4 -71,054 -2.87% ✓ $45.9K
Dec 30, 2025 Jan 2, 2026 Werewolf Therapeutics, Inc. Director Sell 40.6 -78,377 -3.07% ✓ $48.4K
Dec 22, 2025 Dec 29, 2025 Werewolf Therapeutics, Inc. Director Sell 26.3 -291,283 -10.25% ✓ $185.2K
Dec 15, 2025 Dec 17, 2025 Werewolf Therapeutics, Inc. Director Sell 45.0 -48,171 -1.67% ✓ $52K
Dec 10, 2025 Dec 12, 2025 Werewolf Therapeutics, Inc. Director Sell 41.3 -82,971 -2.79% ✓ $88.6K
Dec 5, 2025 Dec 9, 2025 Werewolf Therapeutics, Inc. Director Sell 37.5 -95,179 -3.10% ✓ $94.8K
Dec 2, 2025 Dec 4, 2025 Werewolf Therapeutics, Inc. Director Sell 37.5 -128,185 -4.01% ✓ $117.6K
Nov 26, 2025 Dec 1, 2025 Werewolf Therapeutics, Inc. Director Sell 41.3 -91,088 -2.77% ✓ $87.8K
Nov 21, 2025 Nov 25, 2025 Werewolf Therapeutics, Inc. Director Sell 37.5 -125,576 -3.68% ✓ $115.2K
Nov 18, 2025 Nov 20, 2025 Werewolf Therapeutics, Inc. Director Sell 41.3 -102,753 -2.92% ✓ $94.9K
Nov 13, 2025 Nov 17, 2025 Werewolf Therapeutics, Inc. Director Sell 37.5 -134,553 -3.69% ✓ $128.8K
Nov 7, 2025 Nov 12, 2025 Werewolf Therapeutics, Inc. Director Sell 37.5 -137,041 -3.62% ✓ $154.9K
Nov 4, 2025 Nov 6, 2025 Werewolf Therapeutics, Inc. Director Sell 37.5 -155,885 -3.95% ✓ $189.8K
Oct 30, 2025 Nov 3, 2025 Werewolf Therapeutics, Inc. Director Sell 35.0 -189,356 -4.58% ✓ $251.3K
Oct 27, 2025 Oct 29, 2025 Werewolf Therapeutics, Inc. Director Sell 35.0 -177,145 -4.11% ✓ $286.5K
Mar 27, 2025 Apr 30, 2025 Werewolf Therapeutics, Inc. Director Sell 52.5 -2,425 -0.06% ✗ $2.5K
Dec 10, 2024 Dec 12, 2024 Entrada Therapeutics, Inc. 10% Owner Sell 20.0 -44,722 -1.01% ✗ $917.1K
Nov 2, 2021 Nov 4, 2021 Entrada Therapeutics, Inc. 10% Owner Buy 87.5 +100,000 2.31% ✗ $2M
May 4, 2021 May 6, 2021 Werewolf Therapeutics, Inc. Director Buy 92.5 +150,799 3.65% ✗ $2.4M
Jun 23, 2020 Jun 25, 2020 Repare Therapeutics Inc. 10% Owner Buy 96.3 +250,000 9.08% ✗ $5M
Oct 10, 2017 Oct 11, 2017 RHYTHM PHARMACEUTICALS, INC. 10% Owner Buy 92.5 +100,000 3.85% ✗ $1.7M
Jun 12, 2013 Jun 13, 2013 Pacira BioSciences, Inc. Director Sell 38.8 -22,746 -2.69% ✓ $683.9K
Jun 3, 2013 Jun 4, 2013 Pacira BioSciences, Inc. Director Sell 23.8 -82,072 -8.83% ✓ $2.5M
May 30, 2013 Jun 3, 2013 Pacira BioSciences, Inc. Director Sell 27.5 -54,517 -5.54% ✓ $1.6M
May 28, 2013 May 30, 2013 Pacira BioSciences, Inc. Director Sell 13.8 -215,528 -17.97% ✓ $6.7M
May 22, 2013 May 23, 2013 Pacira BioSciences, Inc. Director Sell 47.5 -7,340 -0.61% ✓ $220.2K
May 20, 2013 May 21, 2013 Pacira BioSciences, Inc. Director Sell 42.5 -13,550 -1.11% ✓ $406.5K
Apr 12, 2013 May 8, 2013 Pacira BioSciences, Inc. Director Sell 40.0 -3,416 -0.25% ✗ $100.1K
Apr 23, 2013 Apr 29, 2013 Pacira BioSciences, Inc. Director Sell 23.8 -114,418 -8.80% ✓ $3.4M
Apr 12, 2013 Apr 18, 2013 Pacira BioSciences, Inc. Director Sell 45.0 -12,575 -0.96% ✓ $377.3K
Feb 1, 2012 Feb 3, 2012 Verastem, Inc. Other Buy 95.0 +100,000 5.17% ✗ $1M
Nov 3, 2010 Nov 5, 2010 Altimmune, Inc. 10% Owner Buy 95.0 +430,000 7.27% ✗ $1.5M